Lindsay J. Bawden - Concepedia

Author

Lindsay J. Bawden

Institute of Cancer Research

Also Known As

L Bawden, L J Bawden, L. Bawden, L.J. Bawden, LINDSAY J. BAWDEN, Lindsay Bawden, Lindsay J. Bawden

Publications

816

Citations

H-Index

Concepts

All Affiliations

Institute of Cancer Research BTG International (United Kingdom)

About

Lindsay J. Bawden is an author at Institute of Cancer Research specializing in cell biology, medicine, and cell signaling.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	3	3	149
2	Cell Biology	3	3	149
3	Natural Sciences	1	1	13
4	Biochemistry	1	1	13
5	Immunology	1	1	70

Lindsay J. Bawden

Publications

805

Citations

H-Index

Page 1

	Year	Citations
Inhibition of the metastatic spread and growth of B16‐BL6 murine melanoma by a synthetic matrix metalloproteinase inhibitor Renato G. S. Chirvi, Angela Garofalo, M Crimmin, International Journal of Cancer	1994	218
CHR-2797: An Antiproliferative Aminopeptidase Inhibitor that Leads to Amino Acid Deprivation in Human Leukemic Cells David Krige, Lindsey Needham, Lindsay J. Bawden, Cancer Research	2008	116
Discovery of 2-(6-{[(6-Fluoroquinolin-2-yl)methyl]amino}bicyclo[3.1.0]hex-3-yl)-<i>N</i>-hydroxypyrimidine-5-carboxamide (CHR-3996), a Class I Selective Orally Active Histone Deacetylase Inhibitor David Moffat, Sanjay R. Patel, Francesca A. Day, Journal of Medicinal Chemistry	2010	82
BB-10010: an active variant of human macrophage inflammatory protein-1 alpha with improved pharmaceutical properties MG Hunter, Lindsay J. Bawden, Deborah H. Brotherton, Blood	1995	71
Cell-targeted PD-1 agonists that mimic PD-L1 are potent T cell inhibitors Adam P. Curnock, Giovanna Bossi, Jyothi Kumaran, JCI Insight Key Immune CheckpointT-regulatory CellImmunologyImmunoeditingImmunologic Mechanism	2021	70
Drug Targeting to Monocytes and Macrophages Using Esterase-Sensitive Chemical Motifs Lindsey Needham, Alan H. Davidson, Lindsay J. Bawden, Journal of Pharmacology and Experimental Therapeutics	2011	68
Two PDGF-B chain residues, arginine 27 and isoleucine 30, mediate receptor binding and activation. John M. Clements, Lindsay J. Bawden, R.E. Bloxidge, The EMBO Journal Molecular PharmacologyMediate Receptor BindingSignal TransductionMolecular PhysiologySignaling Pathway	1991	66
Inhibition of tumour growth by marimastat in a human xenograft model of gastric cancer: relationship with levels of circulating CEA Sue‐Ann Watson, Teresa Morris, Hilary M. Collins, British Journal of Cancer	1999	56
A phase I first‐in‐human study with tefinostat – a monocyte/macrophage targeted histone deacetylase inhibitor – in patients with advanced haematological malignancies Gert J. Ossenkoppele, Bob Löwenberg, Pierre Zachée, British Journal of Haematology	2013	45
Purification and analysis of proteinase-resistant mutants of recombinant platelet-derived growth factor-BB exhibiting improved biological activity A.L. Cook, P M Kirwin, Stewart Craig, Biochemical Journal Molecular BiologyCell GrowthPdgf-receptor BindingThrombosisProtein Expression	1992	13

Page 1